Establishment Labs Holdings Inc (ESTA) Stock Analysis

Q: What is the ESTA stock price target?

Take-profit $78.40 (+19.2% upside). Prior stop was $61.16.

Q: What are the risks of investing in ESTA?

Concentration risk — Supplier: single-source medical-grade silicone supplier; Risk below floor (1.9 < 3.0); Value-trap signals (2/5): High leverage (D/E 6.8), Material insider selling (16 sells, 0.02% of cap); Risk below floor (1.9 < 3.0); Value-trap signals (2/5): High leverage (D/E 6.8), Material insider selling (16 sells, 0.02% of cap).

Q: Is ESTA overvalued or undervalued?

Establishment Labs Holdings Inc trades at a P/E of N/A (forward 876.8). TrendMatrix value score: 4.3/10. Overall verdict: Sell.

Q: What do analysts say about ESTA?

15 analysts cover ESTA with a consensus score of 4.2/5. Average price target: $90.

Q: What does Establishment Labs Holdings Inc do?

Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and reconstruction, registered in 100+ countries including the U.S. (FDA PMA approved September 2024). Revenue is predominantly from Motiva Implant sales; newer products include Mia Femtech (minimally invasive augmentation) and Preservé.

Range Bound setup

SellVALUE-TRAP 2/5Moderate ConfidenceUpdated 4 days ago (May 16, 2026, 10:26 PM ET)

Healthcare · Medical Devices

Sell if holding. Engine safety override at $65.76: Risk below floor (1.9 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: High short interest: 16%; Below-average business quality; Negative price momentum.

Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and reconstruction, registered in 100+ countries including the U.S. (FDA PMA approved September 2024). Revenue is predominantly from Motiva Implant sales; newer products... Read more

$65.76+19.2% A.UpsideScore 5.2/10#30 of 40 Medical Devices

QualityF-score6 / 9FCF yield—

Stop $61.16Target $78.40(analyst − 13%)A.R:R 1.4:1

Analyst target$90.11+37.0%9 analysts

$78.40our TP

$65.76price

$90.11mean

$100

Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 82d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

Recent Developments — Establishment Labs Holdings Inc

Latest news

BTIG Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $90 — benzinga May 7, 2026 positive
Earnings Scheduled For May 6, 2026 — benzinga May 6, 2026 neutral
10 Health Care Stocks Whale Activity In Today's Session — benzinga May 6, 2026 neutral
Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript — benzinga May 6, 2026 neutral
Establishment Labs Hldgs Raises FY2026 Sales Guidance from $264.000M-$266.000M to $266.500M-$268.500M vs $264.984M Est — benzinga May 6, 2026 positive

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards

No bull case signals

Risks

Concentration risk — Supplier: single-source medical-grade silicone supplier

Risk below floor (1.9 < 3.0)

Value-trap signals (2/5): High leverage (D/E 6.8), Material insider selling (16 sells, 0.02% of cap)

Key Metrics

P/E (TTM)—

P/E (Fwd)876.8

Mkt Cap$1.9B

EV/EBITDA-113.5

Profit Mgn-19.1%

ROE-164.0%

Rev Growth44.7%

Beta1.12

DividendNone

Rating analysts15

Quality Signals

Piotroski F6/9MoatNarrow

Concentration Risks(10-K Item 1A)

HIGHSuppliersingle-source medical-grade silicone supplier
10-K Item 1A: 'We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value4.315%0.64

Quality4.615%0.69

Growth10.015%1.50

Momentum3.210%0.32

Sentiment7.510%0.75

Insider Activity3.010%0.30

Peer Rank2.910%0.29

Technical Setup6.55%0.33

Risk Profile1.95%0.10

Catalyst6.45%0.32

Overall (Σ contributions)5.24

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Volatile — 6.9% daily ATR makes tight stops impractical. Position-size conservatively.static

Volatility

0.0

Debt Equity

0.0

Days To Cover

1.1

Short Interest

1.9

Beta

6.5

High short interest justified: 16%Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank

0.8

Value Rank

1.0

Growth Rank

9.8

Industry growth leader

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd

0.0

Obv

1.0

Volume

3.3

Rsi

5.5

Ma Position

6.0

Volume distribution (falling OBV)Above 200-day MA

GatesMomentum 3.2<4.5A.R:R 1.4 < 1.5@spotInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 82d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive

RSI

51 · Neutral

↓ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $61.09Resistance $76.49

Price Targets

$61

$78

A.Upside+19.2%

A.R:R1.4:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Risk below floor (1.9 < 3.0)

! Value-trap signals (2/5): High leverage (D/E 6.8), Material insider selling (16 sells, 0.02% of cap)

! Momentum score 3.2/10 — below 4.5 minimum

Earnings

2/4 beats

Next Earnings2026-08-06 (82d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is ESTA stock a buy right now?

Sell if holding. Engine safety override at $65.76: Risk below floor (1.9 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: High short interest: 16%; Below-average business quality; Negative price momentum. Chart setup: RSI 51 mid-range, Bollinger mid-band. Prior stop was $61.16. Score 5.2/10, moderate confidence.

What is the ESTA stock price target?

Take-profit target: $78.40 (+19.2% upside). Prior stop was $61.16. Stop-loss: $61.16.

What are the risks of investing in ESTA?

Concentration risk — Supplier: single-source medical-grade silicone supplier; Risk below floor (1.9 < 3.0); Value-trap signals (2/5): High leverage (D/E 6.8), Material insider selling (16 sells, 0.02% of cap).

Is ESTA overvalued or undervalued?

Establishment Labs Holdings Inc trades at a P/E of N/A (forward 876.8). TrendMatrix value score: 4.3/10. Verdict: Sell.

What do analysts say about ESTA?

15 analysts cover ESTA with a consensus score of 4.2/5. Average price target: $90.

What does Establishment Labs Holdings Inc do?Establishment Labs develops and commercializes Motiva silicone gel-filled breast implants for augmentation and...